Journal article
A Novel Method for Identifying the Transition Zone in Long-Segment Hirschsprung Disease: Investigating the Muscle Unit to Ganglion Ratio
W Yang, J Pham, SK King, DF Newgreen, HM Young, LA Stamp, MM Hao
Biomolecules | Published : 2022
DOI: 10.3390/biom12081101
Abstract
Hirschsprung disease (HSCR) is characterised by the absence of enteric ganglia along variable lengths of the distal bowel. Current gold standard treatment involves the surgical resection of the defective, aganglionic bowel. Clear and reliable distinction of the normoganglionated bowel from the transition zone is key for successful resection of the entire defective bowel, and the avoidance of subsequent postoperative complications. However, the intraoperative nature of the tissue analysis and the variability of patient samples, sample preparation, and operator objectivity, make reproducible identification of the transition zone difficult. Here, we have described a novel method for using muscl..
View full abstractRelated Projects (2)
Grants
Awarded by Takeda Pharmaceutical Company
Funding Acknowledgements
This project was funded by a grant from the Medical Research Future Fund (MRFF: APP2009049) from the National Health and Medical Research Council, Australia (NHMRC) (to LAS, SKK and MMH) and REACHirschsprung Foundation Research Grant (to LAS, MMH and SKK). LAS and MMH are fellows of the Australian Research Council (ARC DECRA: DE180100261 and DE190101209, respectively).